BeOne Medicines Ltd. (ADR)

General ticker "ONC" information:

  • Sector: Health Care
  • Industry: Medical - Pharmaceuticals
  • Capitalization: $33.1B (TTM average)

BeOne Medicines Ltd. (ADR) follows the US Stock Market performance with the rate: 49.0%.

Estimated limits based on current volatility of 1.1%: low 290.06$, high 296.29$

Factors to consider:

  • Earnings expected soon, date: 2026-05-06 bmo
  • Total employees count: 240 as of 2015
  • Current price 35.0% above estimated high
  • Earnings for 12 months up through Q4 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [133.00$, 265.19$]
  • 2025-12-31 to 2026-12-31 estimated range: [104.72$, 217.69$]

Financial Metrics affecting the ONC estimates:

  • Negative: with PPE of -29.3 at the end of fiscal year the price was very high
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -0.74 <= 0.07
  • Positive: Industry inventory ratio change (median), % of -0.21 <= -0.15
  • Positive: -4.45 < Investing cash flow per share per price, % of -2.89
  • Positive: 42.60 < Shareholder equity ratio, % of 56.28 <= 64.25
  • Negative: negative Net income
  • Positive: Inventory ratio change, % of -2.98 <= -0.75

Similar symbols

Short-term ONC quotes

Long-term ONC plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue $2,458.78MM $3,810.24MM
Operating Expenses $3,666.51MM $4,378.44MM
Operating Income $-1,207.74MM $-568.20MM
Non-Operating Income $381.90MM $35.20MM
R&D Expense $1,778.59MM $1,953.30MM
Income(Loss) $-825.84MM $-533.00MM
Taxes $55.87MM $111.78MM
Profit(Loss)* $-881.71MM $-644.79MM
Stockholders Equity $3,537.33MM $3,332.22MM
Inventory $416.12MM $494.99MM
Assets $5,805.27MM $5,920.91MM
Operating Cash Flow $-1,157.45MM $-140.63MM
Capital expenditure $596.26MM $529.14MM
Investing Cash Flow $60.00MM $-548.35MM
Financing Cash Flow $416.48MM $193.45MM
Earnings Per Share** $-8.45 $-6.12
Ordinary share to ADR 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.